Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995–2012

References

• Degano IR, Salomaa V, Veronesi G, et al. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart. 2015;101:1413–1421.
   PubMed Web of Science ®Google Scholar
• Wang OJ, Wang Y, Chen J, et al. Recent trends in hospitalization for acute myocardial infarction. Am J Cardiol. 2012;109:1589–1593.
   PubMed Web of Science ®Google Scholar
• Cardiovascular Disease Register. 2016. [Internet]; Available from: http://www.thl.fi/cvdr
   Google Scholar
• Statistics Finland. 2016. [Internet]; Availble from: http://www.stat.fi
   Google Scholar
• Salomaa V, Havulinna AS, Koukkunen H, et al. Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future. Heart. 2013;99:954–959.
   PubMed Web of Science ®Google Scholar
• Guzman Castillo M, Gillespie DO, Allen K, et al. Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing. PLoS One. 2014;9:e99482.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–944.
   PubMed Web of Science ®Google Scholar
• Salomaa V, Ketonen M, Koukkunen H, et al. The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993–2002: the FINAMI study. Eur Heart J. 2006;27:2394–2399.
   PubMed Web of Science ®Google Scholar
• Koukkunen H, Salomaa V, Lehto S, et al. Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study. Am J Geriatr Cardiol. 2008;17:78–86.
   PubMedGoogle Scholar
• Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003;108:2543–2549.
   PubMed Web of Science ®Google Scholar
• Charlson ME. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Schmidt M, Jacobsen JB, Lash TL, et al. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 2012;344:e356.
   PubMed Web of Science ®Google Scholar
• O’Connell RL, Lim LL. Utility of the Charlson comorbidity index computed from routinely collected hospital discharge diagnosis codes. Methods Inf Med. 2000;39:7–11.
   PubMed Web of Science ®Google Scholar
• Waterhouse J, Muir C, Correa P, eds. Cancer incidence in five continents. Lyon (France): International Agency for Research on Cancer; 1976.
   Google Scholar
• Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583–612.
   PubMed Web of Science ®Google Scholar
• Salomaa V, Miettinen H, Kuulasmaa K, et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. Circulation. 1996;94:3130–3137.
   PubMed Web of Science ®Google Scholar
• R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria; 2016. [Internet]; Available from: https://www.R-project.org
   Google Scholar
• Kivimäki M, Batty GD, Hamer M, et al. Influence of retirement on nonadherence to medication for hypertension and diabetes. CMAJ. 2013;185:E784–E790.
   PubMed Web of Science ®Google Scholar
• Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27:1153–1158.
   PubMed Web of Science ®Google Scholar
• Salomaa V, Pääkkönen R, Hämäläinen H, et al. Use of secondary preventive medications after the first attack of acute coronary syndrome. Eur J Cardiovasc Prev Rehabil. 2007;14:386–391.
   PubMedGoogle Scholar
• Sulo G, Vollset SE, Nygard O, et al. Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a Cardiovascular Disease in Norway Project). Am J Cardiol. 2014;113:1777–1781.
   PubMed Web of Science ®Google Scholar
• Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe: epidemiological update. Eur Heart J. 2013;34:3028–3034.
   PubMed Web of Science ®Google Scholar
• Nichols M, Townsend N, Scarborough P, et al. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009. Eur Heart J. 2013;34:3017–3027.
   PubMed Web of Science ®Google Scholar
• Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA. 2004;292:1433–1439.
   PubMed Web of Science ®Google Scholar
• Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929–940.
   PubMed Web of Science ®Google Scholar
• Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet. 2016;387:1057–1065.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Wallentin L, Simoons M, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J. 2006;27:789–795.
   PubMed Web of Science ®Google Scholar
• Schoenenberger AW, Radovanovic D, Windecker S, et al. Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome. Eur Heart J. 2016;37:1304–1311.
   PubMed Web of Science ®Google Scholar
• Milcent C, Dormont B, Durand-Zaleski I, et al. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation. 2007;115:833–839.
   PubMed Web of Science ®Google Scholar
• Kang SH, Suh JW, Yoon CH, et al. Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry). Am J Cardiol. 2012;109:787–793.
   PubMed Web of Science ®Google Scholar
• Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–2619.
   PubMed Web of Science ®Google Scholar
• Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2011;32:2999–3054.
   PubMed Web of Science ®Google Scholar
• Bauer T, Koeth O, Junger C, et al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J. 2007;28:2873–2878.
   PubMed Web of Science ®Google Scholar